Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
55°
Clear
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Moderna, Inc.
< Previous
1
2
3
4
5
Next >
Moderna Announces FDA Authorization of Third Dose of COVID-19 Vaccine for Immunocompromised Individuals
August 13, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces New Study Showing Its COVID-19 Vaccine Maintains Antibodies Against Variants of Concern and Interest to 6 Months
August 12, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine
August 09, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Named Fast Company’s 2021 Best Workplace for Innovators
August 06, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
August 05, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Receives FDA Fast Track Designation for Respiratory Syncytial Virus (RSV) Vaccine (mRNA-1345)
August 03, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces First Participant Dosed in Phase 1 Study of Its IL-2 mRNA Therapeutic
August 02, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union
July 23, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces Establishment of New Charitable Foundation
July 22, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023
July 22, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022
July 20, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna to Report Second Quarter Financial Results on Thursday, August 5, 2021
July 15, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces Supply Agreement with Argentina for 20 Million Doses of its COVID-19 Vaccine
July 12, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine
July 07, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces Recipharm Site in France Manufacturing COVID-19 Vaccine Moderna Following Approval by European Medicines Agency
July 01, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces Emergency Use Authorization for its COVID-19 Vaccine Granted by Government of India
June 29, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Provides a Clinical Update on the Neutralizing Activity of its COVID-19 Vaccine on Emerging Variants Including the Delta Variant First Identified in India
June 29, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Kate Cronin to Join Moderna as Chief Brand Officer on July 12
June 28, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
European Commission Purchases Additional 150 Million Doses of Moderna’s COVID-19 Vaccine for Delivery in 2022
June 22, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Reaffirms Commitment to Job Creation in Massachusetts
June 18, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
U.S. Government Purchases Additional 200 Million Doses of Moderna’s COVID-19 Vaccine
June 16, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna and Magenta Partner to Distribute Moderna’s COVID-19 Vaccine and Updated Variant Booster Candidates in United Arab Emirates
June 15, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Dr. Paul Burton to Join Moderna as Chief Medical Officer
June 14, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Submits Authorization Application for its COVID-19 Vaccine in Adolescents in Switzerland
June 14, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna and Tabuk Pharmaceuticals Partner to Commercialize Moderna’s COVID-19 Vaccine in Saudi Arabia
June 11, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Files for Emergency Use Authorization for its COVID-19 Vaccine in Adolescents in the United States
June 10, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel
June 07, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents
June 07, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
June 07, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
Moderna Announces Agreement to Supply the Republic of Botswana with its COVID-19 Vaccine
June 03, 2021
From
Moderna, Inc.
Via
Business Wire
Tickers
MRNA
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.